Legend Biotech - Stock Price History | LEGN

Historical daily share price chart and data for Legend Biotech since 2022 adjusted for splits. The latest closing stock price for Legend Biotech as of May 20, 2022 is 42.61.
  • The all-time high Legend Biotech stock closing price was 56.98 on October 11, 2021.
  • The Legend Biotech 52-week high stock price is 58.00, which is 36.1% above the current share price.
  • The Legend Biotech 52-week low stock price is 30.75, which is 27.8% below the current share price.
  • The average Legend Biotech stock price for the last 52 weeks is 42.87.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Legend Biotech Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 38.5509 27.9900 56.9800 23.5500 46.6100 65.52%
2020 32.1928 37.0000 42.5600 25.8000 28.1600 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.572B $0.090B
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's lead product consist LCAR-B38M/JNJ-4528, which are in clinical stage. Legend Biotech Corporation is based in Cayman Islands.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $162.213B 9.87
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.280B 16.23
Biohaven Pharmaceutical Holding (BHVN) United States $10.017B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.593B 0.00
Emergent Biosolutions (EBS) United States $1.775B 7.60
Arcus Biosciences (RCUS) United States $1.357B 34.40
Myovant Sciences (MYOV) United Kingdom $1.000B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.486B 0.00
Gelesis Holdings (GLS) United States $0.360B 0.00
Zymeworks (ZYME) Canada $0.346B 0.00
Ambrx Biopharma (AMAM) United States $0.149B 0.00
Enzo Biochem (ENZ) United States $0.116B 23.80
SQZ Biotechnologies (SQZ) United States $0.099B 0.00